June 18 (Bloomberg) -- Pfizer Inc. faces a Texas trial over its hormone-replacement drugs after a judge overseeing lawsuits over the medicines sent 200 cases back to their home courts.
June 18 (Bloomberg) -- Pfizer Inc. faces a Texas trial over its hormone-replacement drugs after a judge overseeing lawsuits over the medicines sent 200 cases back to their home courts.